Compare Nvidia Corp (NVDA) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nvidia Corp vs Oruka Therapeutics Inc. Common Stock — how do they compare? Nvidia Corp trades at $218.95 (market cap $5.52T), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B). The key difference: Nvidia Corp is far larger — about 1065.6× Oruka Therapeutics Inc. Common Stock's market cap, and Nvidia Corp pays a 0.44% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nvidia Corp for 116 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| NVDA | ORKA | |
|---|---|---|
Market Cap | $5.52T | $5.18B |
Volume | 84,036,941 | 490,798 |
Sector | Technology | Health |
52-Week High | $239.27 | $113.08 |
52-Week Low | $165.17 | $26.19 |
Typical Hold Time | 116 Days | 0 Days |
Enterprise Value | $5.49T | $4.31B |
Dividend Yield | 0.44% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NVIDIA (NVDA) trades at $221.51, down 2.13% today, amid a mixed technical and fundamental backdrop. The stock shows a bullish moving average signal but neutral oscillators, with key support at $221. Fundamentally, the company reported stellar revenue growth to $130.50 billion in 2025 and a net income margin of 63.66%, though valuation ratios like a P/E of 28.89 and P/S of 18.4 remain elevated. Recent news highlights AI-driven growth potential but also concerns over market saturation.
Outlook: Strong AI demand and earnings beats support long-term growth, but high valuations and competitive pressures pose risks. Analyst consensus is bullish with a $339.17 price target, suggesting significant upside if execution continues.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nvidia Corp
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
